» Articles » PMID: 31300805

Wisteria Floribunda Agglutinin-positive Mac-2 Binding Protein As an Age-independent Fibrosis Marker in Nonalcoholic Fatty Liver Disease

Abstract

The assessment of liver fibrosis is essential because it correlates with mortality risk in nonalcoholic fatty liver disease (NAFLD). This study aims to examine whether serum fibrosis markers could identify candidate patients likely to have advanced fibrosis. We enrolled 352 patients with NAFLD and performed liver biopsies in 97 patients. The area under the receiver operating characteristic curve (AUROC) of liver stiffness by magnetic resonance elastography for histological advanced fibrosis was 0.910, and the optimal cutoff value was 4.07 kPa. To predict severe liver stiffness (≥4.07 kPa), the AUROC for Wisteria floribunda agglutinin-positive mac-2 binding protein (WFA-M2BP) and FIB-4 were 0.897 (cutoff value, 1.08) and 0.880 (cutoff value, 2.53), respectively. After stratification of patients into four age groups as quartile, the optimal cutoff values of WFA-M2BP for predicting severe liver stiffness were similar in each group (1.09, 1.08, 1.10, and 1.12). On the other hand, those of FIB-4 increased in parallel with age (1.47, 2.19, 2.99, and 3.88). In conclusion, WFA-M2BP was precise for estimating severe liver stiffness in NAFLD with single cutoff value independent of age. Hence, identifying high-risk cases using WFA-M2BP from a large number of NAFLD patients is clinically significant.

Citing Articles

Diagnostic Performance of Serum Mac-2-Binding Protein Glycosylation Isomer as a Fibrosis Biomarker in Non-Obese and Obese Patients with MASLD.

Ananchuensook P, Moonlisarn K, Boonkaew B, Bunchorntavakul C, Tangkijvanich P Biomedicines. 2025; 13(2).

PMID: 40002828 PMC: 11853689. DOI: 10.3390/biomedicines13020415.


Utility of Mac-2 binding protein glycosylation isomer as an excellent biomarker for the prediction of liver fibrosis, activity, and hepatocellular carcinoma onset: an expert review.

Kamada Y, Sumida Y, Takahashi H, Fujii H, Miyoshi E, Nakajima A J Gastroenterol. 2024; 60(1):10-23.

PMID: 39652103 DOI: 10.1007/s00535-024-02179-8.


KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease.

Kim M, Han J, An J, Kim B, Jin Y, Kim S Clin Mol Hepatol. 2024; 30(Suppl):S5-S105.

PMID: 39159947 PMC: 11493350. DOI: 10.3350/cmh.2024.0506.


Enhanced Liver Fibrosis Score for Diagnosing Liver Fibrosis in Chronic Hepatitis.

Tamaki N, Takaura K, Higuchi M, Yasui Y, Itakura J, Tsuchiya K Diagnostics (Basel). 2024; 14(13).

PMID: 39001207 PMC: 11240480. DOI: 10.3390/diagnostics14131317.


Detecting advanced liver fibrosis using ultrasound shear wave velocity measurement in the general population.

Kirino S, Tamaki N, Kurosaki M, Takahashi Y, Higuchi M, Itakura Y Quant Imaging Med Surg. 2023; 13(10):6493-6502.

PMID: 37869309 PMC: 10585500. DOI: 10.21037/qims-23-511.


References
1.
Takahashi Y, Kurosaki M, Tamaki N, Yasui Y, Hosokawa T, Tsuchiya K . Non-alcoholic fatty liver disease fibrosis score and FIB-4 scoring system could identify patients at risk of systemic complications. Hepatol Res. 2014; 45(6):667-75. DOI: 10.1111/hepr.12405. View

2.
Angulo P, Kleiner D, Dam-Larsen S, Adams L, Bjornsson E, Charatcharoenwitthaya P . Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2015; 149(2):389-97.e10. PMC: 4516664. DOI: 10.1053/j.gastro.2015.04.043. View

3.
Kawanaka M, Tomiyama Y, Hyogo H, Koda M, Shima T, Tobita H . Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts the development of hepatocellular carcinoma in patients with non-alcoholic fatty liver disease. Hepatol Res. 2018; 48(7):521-528. DOI: 10.1111/hepr.13054. View

4.
Atsukawa M, Tsubota A, Okubo T, Arai T, Nakagawa A, Itokawa N . Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein more reliably distinguishes liver fibrosis stages in non-alcoholic fatty liver disease than serum Mac-2 binding protein. Hepatol Res. 2017; 48(6):424-432. DOI: 10.1111/hepr.13046. View

5.
Ito T, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Hayashi K . Utility and limitations of noninvasive fibrosis markers for predicting prognosis in biopsy-proven Japanese non-alcoholic fatty liver disease patients. J Gastroenterol Hepatol. 2018; 34(1):207-214. DOI: 10.1111/jgh.14448. View